BUSINESS● ELEVATEDJul 16 · Jul 16, 2026, 1:59 AM
Why the West has an uphill task challenging China in pharmaceutical ingredients
South China Morning Post
From rare earth elements to commercial drones, Washington has become all too familiar with the strongest weapons in Beijing’s manufacturing arsenal – the materials and products where China holds a strategic advantage in production, extraction or any other link in the supply chain. After those near-monopolies provided Chinese policymakers considerable leverage in last year’s trade dispute, US think tanks are asking whether pharmaceuticals represent the next critical dependency. Their concern is...
GlobeAlert aggregates and classifies open sources; the story above belongs to its publisher. Summaries are machine-generated from the source text.
More in Business
BUSINESSnowMunicipal Securities Underwriters Pay a Total of $325,000 in FinesSECBUSINESSnowSEC CHAIRMAN ARTHUR LEVITT, IOWA OFFICIALS TO HOLD INVESTORS’ TOWN MEETING IN DES MOINESSECBUSINESS44m agoAmerican Battery Technology Non-GAAP EPS of $1.70, revenue of $21.7MSeeking Alpha TechBUSINESS1h agoPeter Navarro says Fed’s rate raise is ‘a bad decision’The Hill